Xinlai Cheng

17PUBLICATIONS
27CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Characterisation of biological macromoleculesMolecular targetsReaction engineering (excl. nuclear reactions)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 22, 2025
Targeting the Spliceosomal Protein USP39 Through Allosteric Ligands and PROTAC-Induced Degradation.

Daniel Schäfer, Cristian Prieto-Garcia, Jianhui Wang

|Oct 22, 2025
A Chemically Induced CRISPR/dCas13FCPF Platform for Precise and Programmable RNA Regulation.

Sebastian Hasselbeck, Jianhui Wang, Zhaodai Bai

|Mar 27, 2025
Evolutionary divergence in CTCF-mediated chromatin topology drives transcriptional innovation in humans.

Xia Wu, Dan Xiong, Rong Liu

|Sep 24, 2024
Chem-CRISPR/dCas9FCPF: a platform for chemically induced epigenome editing.

Mukaddes Altinbay, Jianhui Wang, Jie Chen

|Jan 23, 2024
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy.

Sebastian Hasselbeck, Xinlai Cheng

|May 27, 2023
Recent Advances in Covalent Drug Discovery.

Daniel Schaefer, Xinlai Cheng

Pageof 3

Frequent Collaborators

2 joint publications

Stefan Wölfl

2 joint publications

Miguel A Andrade-Navarro

2 joint publications

Stefan Knapp

1 joint publications

Clara-Marie Gürth